Array BioPharma: Fiscal 2Q Earnings Snapshot

February 5, 2019

BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Tuesday reported a loss of $11.4 million in its fiscal second quarter.

The Boulder, Colorado-based company said it had a loss of 5 cents per share.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.

The drug developer posted revenue of $82.5 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $49 million.

Array BioPharma shares have climbed 33 percent since the beginning of the year. The stock has increased 27 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARRY at https://www.zacks.com/ap/ARRY